El mercado de antígenos virales se valoró en 101,41 millones de dólares en 2019 y se prevé que alcance los 236,80 millones de dólares en 2027; se espera que crezca a una tasa compuesta anual del 11,0 % durante 2020-2027.
Un virus puede infectar todo tipo de formas de vida, desde plantas y animales hasta arqueas y bacterias. Un antígeno viral es un veneno o sustancia tóxica administrada por estas entidades virulentas, que induce una reacción inmune en su huésped. Por ejemplo, un antígeno viral se determina mediante IFA en neutrófilos y plaquetas de la médula ósea o la sangre o en suero, saliva, lágrimas o plasma mediante ELISA. También se pueden utilizar pruebas de amplificación nucleica para determinar el estadio de la infección. Los mejores resultados se obtienen cuando los antígenos se miden mediante análisis de sangre o suero.
Un virus puede infectar todo tipo de formas de vida, desde plantas y animales hasta arqueas y bacterias. Un antígeno de virus es un veneno o sustancia tóxica administrada por un virus que induce una reacción inmune en su huésped. Una proteína viral es un antígeno identificado por el genoma viral que puede reconocerse a través de una respuesta inmunológica particular. Un antígeno viral se determina mediante IFA en neutrófilos y plaquetas de la médula ósea o la sangre o en suero, saliva, lágrimas o plasma mediante ELISA. También se pueden utilizar pruebas de amplificación nucleica para determinar el estadio de la infección. Los mejores resultados se obtienen cuando los antígenos se miden mediante análisis de sangre o suero.
regiones lucrativas en el mercado de antígenos viralesPerspectivas del mercado< /p>
La mayor aceptación de los antígenos virales en el desarrollo de vacunas impulsa el crecimiento del mercado
Un antígeno viral es una toxina u otra sustancia liberada por un virus que es capaz de inducir una respuesta inmune (para crear un anticuerpo) en el organismo huésped. Una proteína viral es un antígeno específico del genoma viral que puede reconocerse mediante una respuesta inmunológica específica. La vacunación tiene como objetivo establecer una inmunidad en el huésped que, en caso de un patógeno infeccioso, prevenga la enfermedad. Por lo tanto, en su forma más simple, el desarrollo de vacunas para enfermedades virales implica la distribución de antígenos que inducen anticuerpos neutralizantes específicos del virus y evitan la inducción de cualquier anticuerpo no objetivo.
El desarrollo y uso de vacunas ha tenido un gran impacto. Redujo el número de enfermedades y dolencias a lo largo de los años. La introducción de una variedad de nuevos tipos de vacunas ha sido posible gracias a la manipulación del ADN, el ARN, las proteínas y los azúcares, un mayor conocimiento de la respuesta inmune y un gran avance en la ingeniería genética. El desarrollo de mutantes atenuados, la expresión de posibles antígenos en vectores vivos y la purificación y síntesis directa de antígenos en nuevos sistemas han mejorado significativamente la tecnología de la vacuna.
Products Insights
En términos de componente, el coronavirus El segmento de antígenos tuvo la mayor participación del mercado de antígenos virales en 2019, y se espera que continúe su dominio y registre una CAGR más alta, la más alta del mercado durante el período de pronóstico.
Application Insights
Según el usuario final, el mercado mundial de antígenos virales se segmenta en hospitales, clínicas, laboratorios, centros de diagnóstico, bancos de sangre e institutos de investigación. El segmento de centros de diagnóstico tuvo la mayor participación del mercado en 2019, y se espera que el mercado de laboratorios registre un crecimiento al CAGR más alto durante el período de pronóstico.
Un laboratorio es un lugar donde se realizan pruebas de muestras clínicas. Se lleva a cabo para recopilar información sobre la salud del paciente para ayudar a diagnosticar, tratar y prevenir enfermedades. En las últimas décadas se ha producido una importante revolución en los servicios de los laboratorios de diagnóstico viral y su papel en el tratamiento clínico de los pacientes. Los laboratorios difieren en tamaño y sofisticación y ofrecen una amplia gama de instalaciones de investigación. Se pueden ver servicios más amplios en hospitales de cuidados intensivos y centros médicos que pueden brindar servicios amplios, donde el 70% de las decisiones clínicas se basan en pruebas de laboratorio. Los consultorios médicos, las clínicas y los centros de atención a largo plazo y de enfermería especializada pueden tener laboratorios que ofrezcan servicios de pruebas más básicos. El diagnóstico preciso del virus requiere un examen de laboratorio de muestras clínicas para detectar la presencia de antígenos virales, virus o anticuerpos específicos. En las últimas décadas, se ha producido una revolución significativa en el servicio de los laboratorios de diagnóstico viral y su papel en el manejo clínico de los pacientes.
Perspectivas estratégicas
Actores que operan en el mercado de antígenos virales Adoptar estrategias de colaboración y asociación para satisfacer las demandas de los usuarios finales mediante la introducción de ofertas tecnológicamente avanzadas, y estas estrategias; apoyan significativamente el crecimiento del mercado.
Por componente
- Antígenos virales de la influenza
- Antígenos del coronavirus
- Antígenos del virus Zika< /li>
- Antígenos del virus del Ébola
- Antígenos del virus del dengue
- Antígenos virales del virus del herpes simple (VHS)
- Antígenos virales del rotavirus
- Antígenos del virus de la hepatitis AE
- Antígenos del virus del sarampión
- Antígenos del virus de las paperas/parotitis
- Otros
Por técnica
- ELISA
- Inmunoensayo
- Hemaglutinación
- Radioinmunoensayo (RIA)
- Tinción con inmunoperoxidasa < li>Inmunofluorescencia
- Otros
Por usuario final
- Hospitales
- Clínicas
- Laboratorios
- Centros de Diagnóstico
- Bancos de Sangre
- Institutos de Investigación
Por Geografía
- < li>América del Norte
- Estados Unidos
- Canadá
- México
- Europa
- Francia
- Alemania
- Italia
- Reino Unido
- Rusia
- Asia Pacífico < ul>
- China
- India
- Corea del Sur
- Japón
- Australia
- Sudáfrica
- Arabia Saudita
- EAU
- Brasil
- Argentina
Perfiles de empresas
- Microbix Biosystems
- BIO-RAD LABORATORIES INC.
- Diagnóstico creativo
- Aalto Bio Reagents Ltd.
- Advanced Biotechnologies Inc. < li>Prospec-Tany Technogene Ltd.
- ACROBiosystems.
- MERIDIAN BIOSCIENCE, INC.
- Rekom Biotech SL
- LGC Limited
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
A virus can infect all types of life forms, from plants and animals to archaea and bacteria. A virus antigen is a poison or toxic substance administered by a virus that induces an immune reaction in its host. A viral protein is an antigen identified by the viral genome that can be recognized through a particular immunological response. A viral antigen is determined by IFA in neutrophils and platelets from bone marrow or blood or in serum, saliva, tears, or plasma by ELISA. Nucleic amplification tests can also be used to determine the stage of infection. The best outcomes are obtained when antigens are measured through blood tests or serum.
The global viral antigens market is being driven by factors such increased acceptance of viral antigens in vaccine development and advancements in image analysis software and informatics platforms for viral antigen detection. Furthermore, emerging markets is likely to offer significant opportunities for the growth of the global viral antigens market.
The high cost of vaccine development is the significant factor that will hinder the viral antigens market growth.
The List of Companies - Viral Antigens Market
- Microbix Biosystems
- BIO-RAD LABORATORIES INC.
- Creative Diagnostics
- Aalto Bio Reagents Ltd.
- Advanced Biotechnologies Inc.
- Prospec-Tany Technogene Ltd.
- ACROBiosystems.
- MERIDIAN BIOSCIENCE, INC.
- Rekom Biotech S.L
- LGC Limited
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Dec 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Dec 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Dec 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Dec 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Dec 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Dec 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)